Structure |
Chemical Name |
CAS |
MF |
![Bumetanide Impurity 22](/) |
Bumetanide Impurity 22 |
|
|
![Rocuronium Bromide Impurity 32 、33](/) |
Rocuronium Bromide Impurity 32 、33 |
|
|
![Flucloxacillin Sodium Impurity X](/) |
Flucloxacillin Sodium Impurity X |
|
|
![Pitavastatin Impurity 98](/) |
Pitavastatin Impurity 98 |
|
|
![Perospirone Impurity 29](/) |
Perospirone Impurity 29 |
|
|
![Perospirone Impurity 24](/) |
Perospirone Impurity 24 |
|
|
![Perospirone Impurity 7](/) |
Perospirone Impurity 7 |
1002359-81-0 |
|
![2-methyl-4-(((2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14- tetraen-1-yl)oxy)naphthalen-1-yl acetate](/) |
2-methyl-4-(((2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14- tetraen-1-yl)oxy)naphthalen-1-yl acetate |
|
|
![Paxlovid Impurity 17](/) |
Paxlovid Impurity 17 |
|
|
![NA](/) |
NA |
|
|
![Fondaparinux sodium impurity 16](/) |
Fondaparinux sodium impurity 16 |
|
|
![Fondaparinux Sodium Impurity 11](/) |
Fondaparinux Sodium Impurity 11 |
|
|
![Oxacillin Impurity E](/) |
Oxacillin Impurity E |
|
|
![AZOBENZENE-3-CARBOXYLICACID](/CAS/GIF/14474-22-7.gif) |
AZOBENZENE-3-CARBOXYLICACID |
14474-22-7 |
C13H10N2O2 |
![Bosutinib Impurity 40](/) |
Bosutinib Impurity 40 |
|
|
![Ticagrelor Impurity J&K](/) |
Ticagrelor Impurity J&K |
|
|
![Olodaterol Impurity 24](/) |
Olodaterol Impurity 24 |
|
|
![Miglitol Isomer ImpurityB](/) |
Miglitol Isomer ImpurityB |
|
|
![Chloromethyl ethyl carbonate](/CAS/GIF/35179-98-7.gif) |
Chloromethyl ethyl carbonate |
35179-98-7 |
C4H7ClO3 |
![Bimatoprost Impurity 10](/) |
Bimatoprost Impurity 10 |
|
|
![Carbetocin S-Oxide II](/) |
Carbetocin S-Oxide II |
|
|
![Empagliflozin Impurity 82](/CAS/20210111/GIF/2452301-16-3.gif) |
Empagliflozin Impurity 82 |
2452301-16-3 |
C17H16ClIO2 |
![Empagliflozin Impurity 88](/) |
Empagliflozin Impurity 88 |
|
|
![Tofacitinib Impurity K](/CAS/20211123/GIF/2328165-36-0.gif) |
Tofacitinib Impurity K |
2328165-36-0 |
C16H21N5O3 |
![Olopatadine Impurity 13](/CAS/20210111/GIF/55453-90-2.gif) |
Olopatadine Impurity 13 |
55453-90-2 |
C18H16O4 |
![Avibactam sodium Impurity CIA](/) |
Avibactam sodium Impurity CIA |
|
|
![4-((2-amino-2-oxoethyl)amino)butanoic acid](/CAS/20210111/GIF/1096803-44-9.gif) |
4-((2-amino-2-oxoethyl)amino)butanoic acid |
1096803-44-9 |
C6H12N2O3 |
![Lenvatinib impurity LFZZ-17](/CAS/20181212/GIF/CB68058139.gif) |
Lenvatinib impurity LFZZ-17 |
|
C11H9NO4 |
![Ornidazole Impurity 25](/) |
Ornidazole Impurity 25 |
|
|
![Pitavastatin Impurity 72](/) |
Pitavastatin Impurity 72 |
|
|
![Febuxostat Impurity 109](/) |
Febuxostat Impurity 109 |
|
|
![Brivaracetam Impurity 37](/) |
Brivaracetam Impurity 37 |
|
|
![Ticagrelor Impurity 133](/) |
Ticagrelor Impurity 133 |
|
|
![4-[(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-benzamide](/CAS/20200611/GIF/1187188-59-5.gif) |
4-[(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-benzamide |
1187188-59-5 |
C14H12BNO4 |
![2-Propenoic acid, 3-[4-(hydroxymethyl)phenyl]-](/CAS/20200611/GIF/219915-41-0.gif) |
2-Propenoic acid, 3-[4-(hydroxymethyl)phenyl]- |
219915-41-0 |
C10H10O3 |
![L-Alanine, 3-[(R)-(carboxymethyl)sulfinyl]-](/CAS/20200611/GIF/61475-35-2.gif) |
L-Alanine, 3-[(R)-(carboxymethyl)sulfinyl]- |
61475-35-2 |
C5H9NO5S |
![Phenol, 2-(2-phenyldiazenyl)-](/CAS/20200611/GIF/2362-57-4.gif) |
Phenol, 2-(2-phenyldiazenyl)- |
2362-57-4 |
C12H10N2O |
![3-Quinolinecarboxylic acid, 1-cyclopropyl-7-fluoro-1,4-dihydro-6,8-dimethoxy-4-oxo-](/CAS/20200611/GIF/2410658-30-7.gif) |
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-fluoro-1,4-dihydro-6,8-dimethoxy-4-oxo- |
2410658-30-7 |
C15H14FNO5 |
![Hexanoic acid, 3-(hydroxymethyl)-](/CAS/20200611/GIF/81381-87-5.gif) |
Hexanoic acid, 3-(hydroxymethyl)- |
81381-87-5 |
C7H14O3 |
![benzhydryl (6R,7S)-7-(2-mercaptoacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate](/) |
benzhydryl (6R,7S)-7-(2-mercaptoacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
|
![43,50-Dicarboxy-cyanoco balamin](/) |
43,50-Dicarboxy-cyanoco balamin |
|
|
![(1R,4S) Sertraline Hydrochloride](/CAS/GIF/79896-32-5.gif) |
(1R,4S) Sertraline Hydrochloride |
79896-32-5 |
C17H18Cl3N |
![4-Desmethoxy-4-chloro Omeprazole Sulfide](/CAS/GIF/220757-74-4.gif) |
4-Desmethoxy-4-chloro Omeprazole Sulfide |
220757-74-4 |
C16H16ClN3OS |
![N-Desmethyl Tamoxifen Hydrochloride](/CAS/GIF/15917-65-4.gif) |
N-Desmethyl Tamoxifen Hydrochloride |
15917-65-4 |
C25H27NO.ClH |
![(3S,5S)-Atorvastatin sodium salt](/CAS/GIF/501121-34-2.gif) |
(3S,5S)-Atorvastatin sodium salt |
501121-34-2 |
C33H35FN2O5 |
![2(1H)-Pyrazinone, 3-phenyl-](/CAS/GIF/2882-18-0.gif) |
2(1H)-Pyrazinone, 3-phenyl- |
2882-18-0 |
C10H8N2O |
![1H-Thieno[3,4-d]imidazole-4-valeric acid, hexahydro-2-oxo-, stereoisomer (8CI)](/CAS/20200515/GIF/21788-37-4.gif) |
1H-Thieno[3,4-d]imidazole-4-valeric acid, hexahydro-2-oxo-, stereoisomer (8CI) |
21788-37-4 |
C10H16N2O3S |
![pazufloxacin](/CAS/GIF/166665-94-7.gif) |
pazufloxacin |
166665-94-7 |
C16H15FN2O4 |
![MK 485](/CAS/GIF/28875-92-5.gif) |
MK 485 |
28875-92-5 |
C10H14N2O4 |
![1,3-Dioxane-4-aceticacid,6-(cyanomethyl)-2,2-dimethyl-,(4R,6R)-(9CI)](/CAS/GIF/807312-27-2.gif) |
1,3-Dioxane-4-aceticacid,6-(cyanomethyl)-2,2-dimethyl-,(4R,6R)-(9CI) |
807312-27-2 |
C10H15NO4 |
![bromobenzarone](/CAS/GIF/94729-09-6.gif) |
bromobenzarone |
94729-09-6 |
C17H13BrO3 |
![digoxigenin-bis(digitoxoside)](/CAS/GIF/5297-05-2.gif) |
digoxigenin-bis(digitoxoside) |
5297-05-2 |
C35H54O11 |
![17 alpha-cyanomethyl-19-nortestosterone](/CAS/GIF/67473-36-3.gif) |
17 alpha-cyanomethyl-19-nortestosterone |
67473-36-3 |
C20H27NO2 |
![desmethylazelastine](/CAS/GIF/47491-38-3.gif) |
desmethylazelastine |
47491-38-3 |
C21H22ClN3O |
![(-)-menthyl benzoate](/CAS/GIF/6284-35-1.gif) |
(-)-menthyl benzoate |
6284-35-1 |
C17H24O2 |
![3-methyleneisobenzofuran-1(3H)-one](/CAS2/GIF/3453-63-2.gif) |
3-methyleneisobenzofuran-1(3H)-one |
3453-63-2 |
C9H6O2 |
![Irbesartan impurity A](/CAS/20200331/GIF/CB62514437.gif) |
Irbesartan impurity A |
|
C25H28N6O |
![N-DesMethyl SuMatriptan](/CAS/GIF/88919-51-1.gif) |
N-DesMethyl SuMatriptan |
88919-51-1 |
C13H19N3O2S |
![2-epi-(-)-EMtricitabine](/CAS/GIF/145416-34-8.gif) |
2-epi-(-)-EMtricitabine |
145416-34-8 |
C8H10FN3O3S |
![Parent nucleus of cefotiaM hydrochloride](/CAS/20180808/GIF/372092-19-8.gif) |
Parent nucleus of cefotiaM hydrochloride |
372092-19-8 |
C13H21N7O3S2 |
![Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)](/CAS/20150408/GIF/111664-35-8.gif) |
Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) |
111664-35-8 |
C22H19NO4 |
![N-METHYL-3-CHLORO-3-PHENYL PROPYLAMINE HCL](/StructureFile/ChemBookStructure9/GIF/CB6441012.gif) |
N-METHYL-3-CHLORO-3-PHENYL PROPYLAMINE HCL |
128036-32-8 |
C10H15Cl2N |
![2,4,5-TRIFLUORO-3-METHOXYBENZOIC ACID](/CAS/GIF/11281-65-5.gif) |
2,4,5-TRIFLUORO-3-METHOXYBENZOIC ACID |
11281-65-5 |
C8H5F3O3 |
![METHYL TRIPHENYLMETHYL ETHER](/CAS/GIF/596-31-6.gif) |
METHYL TRIPHENYLMETHYL ETHER |
596-31-6 |
C20H18O |
![CLOPIDOGREL CARBOXYLIC ACID](/CAS/GIF/144457-28-3.gif) |
CLOPIDOGREL CARBOXYLIC ACID |
144457-28-3 |
C15H14ClNO2S |
![RAC (CIS/TRANS) DONEPEZIL N-OXIDE](/CAS/GIF/120013-84-5.gif) |
RAC (CIS/TRANS) DONEPEZIL N-OXIDE |
120013-84-5 |
C24H29NO4 |
![5-Carboxy-2'-deoxyuridine](/CAS/GIF/14599-46-3.gif) |
5-Carboxy-2'-deoxyuridine |
14599-46-3 |
C10H12N2O7 |
![METOPROLOL IMPURITY D](/StructureFile/ChemBookStructure22/GIF/CB6587848.gif) |
METOPROLOL IMPURITY D |
|
C15H25NO3 |
![NITRENDIPINE IMPURITY A](/) |
NITRENDIPINE IMPURITY A |
|
|
![TAMSULOSIN IMPURITY D](/StructureFile/ChemBookStructure22/GIF/CB6588461.gif) |
TAMSULOSIN IMPURITY D |
|
C20H28N2O5S |
![Macitentan Hydroxy amine Impurity](/CAS/20200611/GIF/2211059-05-9.gif) |
Macitentan Hydroxy amine Impurity |
2211059-05-9 |
C12H12BrN3O2 |
![1,3-diethyl-1,3-dimethylurea](/CAS/20210111/GIF/31468-19-6.gif) |
1,3-diethyl-1,3-dimethylurea |
31468-19-6 |
C7H16N2O |
![2,4(1H,3H)-Pyrimidinedione, 6-[(3R)-3-amino-1-piperidinyl]-3-methyl-](/CAS/GIF/2276323-24-9.gif) |
2,4(1H,3H)-Pyrimidinedione, 6-[(3R)-3-amino-1-piperidinyl]-3-methyl- |
2276323-24-9 |
C10H16N4O2 |
![7H-Purine-7-acetic acid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-, ethyl ester](/CAS/GIF/7029-96-1.gif) |
7H-Purine-7-acetic acid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-, ethyl ester |
7029-96-1 |
C11H14N4O4 |
![N-(2-Amino-4,5,6,7-tetrahydro-benzothiazol-6-yl)-acrylamide](/) |
N-(2-Amino-4,5,6,7-tetrahydro-benzothiazol-6-yl)-acrylamide |
|
|
![Rifampin Impurity 6](/) |
Rifampin Impurity 6 |
|
|
![Cefuroxime Dioxide Impurity(Cefuroxime Sulfoxide)](/) |
Cefuroxime Dioxide Impurity(Cefuroxime Sulfoxide) |
|
|
![Ampicillin Impurity F(USP)](/) |
Ampicillin Impurity F(USP) |
|
|
![1-Pyrrolidinecarboxylic acid, 3,3'-dithiobis[5-[(dimethylamino)carbonyl]-, 1,1'-bis[(4-nitrophenyl)methyl] ester, (3S,3'S,5S,5'S)-](/CAS/20211123/GIF/936226-36-7.gif) |
1-Pyrrolidinecarboxylic acid, 3,3'-dithiobis[5-[(dimethylamino)carbonyl]-, 1,1'-bis[(4-nitrophenyl)methyl] ester, (3S,3'S,5S,5'S)- |
936226-36-7 |
C30H36N6O10S2 |
![D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-(1-methylethoxy)phenyl]methyl]phenyl]-, (1S)-](/CAS/20210111/GIF/946525-39-9.gif) |
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-(1-methylethoxy)phenyl]methyl]phenyl]-, (1S)- |
946525-39-9 |
C22H27ClO6 |
![Topiroxostat Impurity 42](/) |
Topiroxostat Impurity 42 |
|
|
![Crisaborole intermediate](/CAS/20210111/GIF/1187188-60-8.gif) |
Crisaborole intermediate |
1187188-60-8 |
C14H13BO4 |
![Regorafenib Impurity MHY](/) |
Regorafenib Impurity MHY |
|
|
![2-Thiazolamine, 5-(4-cyclohexyl-1-piperazinyl)-4-(4,5-dichloro-2-thienyl)-](/CAS/20210111/GIF/570407-63-5.gif) |
2-Thiazolamine, 5-(4-cyclohexyl-1-piperazinyl)-4-(4,5-dichloro-2-thienyl)- |
570407-63-5 |
C17H22Cl2N4S2 |
![INDEX NAME NOT YET ASSIGNED](/CAS/20211123/GIF/2417213-74-0.gif) |
INDEX NAME NOT YET ASSIGNED |
2417213-74-0 |
C42H42N4O12S |
![Lumateperone Impurity 6](/CAS/20210111/GIF/313368-82-0.gif) |
Lumateperone Impurity 6 |
313368-82-0 |
C23H26FN3O |
![1H-?Indole-?5,?6-?diol, 1-?[3-?(4-?hydroxyphenyl)?-?1-?methylpropyl]?-](/CAS/20210111/GIF/2514709-72-7.gif) |
1H-?Indole-?5,?6-?diol, 1-?[3-?(4-?hydroxyphenyl)?-?1-?methylpropyl]?- |
2514709-72-7 |
C18H19NO3 |
![6,6'-oxybis(3-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid)](/) |
6,6'-oxybis(3-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid) |
|
|
![4-Pyrimidineethanol, 6-bromo-α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)-](/CAS/20211123/GIF/1307315-04-3.gif) |
4-Pyrimidineethanol, 6-bromo-α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)- |
1307315-04-3 |
C16H13BrF3N5O |
![Cycloocta[b]pyridine, 2-(4-ethyl-1,4-dioxido-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-](/CAS/20200611/GIF/2247538-61-8.gif) |
Cycloocta[b]pyridine, 2-(4-ethyl-1,4-dioxido-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro- |
2247538-61-8 |
C23H30FN3O2 |
![Vonoprazan Impurity B-3](/) |
Vonoprazan Impurity B-3 |
|
|
![3-Azetidineacetamide, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-](/CAS/20210111/GIF/2271228-51-2.gif) |
3-Azetidineacetamide, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]- |
2271228-51-2 |
C16H19N7O3S |
![Budesonide Impurity 26](/) |
Budesonide Impurity 26 |
|
|
![Peramivir Impurity 48](/) |
Peramivir Impurity 48 |
|
|
![NA](/) |
NA |
|
|
![3-Quinolinemethanol, 2-cyclopropyl-4-phenyl-](/CAS/20210305/GIF/2153433-73-7.gif) |
3-Quinolinemethanol, 2-cyclopropyl-4-phenyl- |
2153433-73-7 |
C19H17NO |
![Avatrombopag Impurity 37](/) |
Avatrombopag Impurity 37 |
|
|
![Piperacillin ImpurityABCDEFGHI](/) |
Piperacillin ImpurityABCDEFGHI |
|
|
![5,6-DIMETHOXY-2-PYRIDIN-4-YLMETHYL-INDAN-1-ONE](/CAS/GIF/4803-57-0.gif) |
5,6-DIMETHOXY-2-PYRIDIN-4-YLMETHYL-INDAN-1-ONE |
4803-57-0 |
C17H17NO3 |
![3-(Dimethylamino)-1-(2-thienyl)-1-propanol](/CAS/GIF/13636-02-7.gif) |
3-(Dimethylamino)-1-(2-thienyl)-1-propanol |
13636-02-7 |
C9H15NOS |